Recombinant Zika Virus Envelope protein (a.a 40-400) [His]

Target

E protein

Nature

Recombinant

Tag/Conjugate

His

Molecular Weight

38 kDa

Alternative Names

E protein ectodomain; Envelope glycoprotein

Purity

> 95% , as determined by SDS-PAGE

Format

Liquid

Concentration

Batch dependent - please inquire should you have specific requirements

Buffer

PBS, with 25mM arginine

Preservative

None

Storage

2-8°C short term, -20°C long term

Introduction

Zika virus is an emerging disease that is spread by Aedes mosquitoes. The virus was first isolated in Central Africa, and has since been spread to South Asia and recently to South America. Zika virus can cause mild fever, rash, myalgia, arthralgia and headaches, with one in four infected individuals being asymptomatic. Due to similar symptoms Zika virus infected individuals can easily be mis-diagnosed as a dengue infection and vice-versa. In addition, Zika virus has been implicated in causing microcephaly through transmission in utero.

Antigen Description

Recombinant Zika envelope protein (strain MR766) is produced by E. coli and the target gene encoding a.a 40-400 is expressed with a His tag at the C-terminus.

Keywords

Zika virus; ZIKV; Envelope protein